SCHEMBL7015277

SCHEMBL7015277

Cc1ccc(-c2cncnc2O)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPS6KA3 P51812 2/20 0.44
KMT2A Q03164 2/20 0.42
DGAT1 O75907 1/20 0.41
SLC9A1 P19634 1/20 0.39
COMT P21964 1/20 0.39
CYP19A1 P11511 1/20 0.39
MAP4K4 O95819 1/20 0.39
NPSR1 Q6W5P4 1/20 0.38
CYP1A2 P05177 3/20 0.38
CYP3A4 P08684 3/20 0.38
CYP2C19 P33261 2/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
ALOX15 P16050 1/20 0.38
HSD17B10 Q99714 1/20 0.38
USP7 Q93009 1/20 0.38
SLC22A12 Q96S37 1/20 0.38
LMNA P02545 2/20 0.38
CYP2D6 P10635 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27399131 0.81 RPS6KA3 (0.46) RPS6KA3KMT2ADGAT1CYP19A1MAP4K4
SCHEMBL7013819 0.77 DGAT1 (0.41) RPS6KA3KMT2ADGAT1SLC9A1NPSR1
SCHEMBL7006231 0.77 DGAT1 (0.67) KMT2ADGAT1SLC9A1MAP4K4NPSR1
SCHEMBL15723948 0.74 CYP17A1 (0.39) RPS6KA3KMT2ADGAT1SLC9A1CYP19A1
SCHEMBL7006695 0.73 ERBB2 (0.47) RPS6KA3DGAT1SLC9A1NPSR1CYP1A2
SCHEMBL31452803 0.73 MAPK9 (0.51) KMT2ACYP1A2CYP3A4CYP2C19KDM4E
SCHEMBL4058284 0.71 MEN1 (0.41) KMT2ACOMTNPSR1KDM4EALDH1A1
SCHEMBL30046665 0.69 DGAT1 (0.56) KMT2ADGAT1MAP4K4NPSR1CYP1A2
SCHEMBL16806007 0.68 GRM5 (0.39) KMT2ACYP19A1NPSR1KDM4EALDH1A1
SCHEMBL28214521 0.68 EGFR (0.39) KMT2ACOMTMAP4K4CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1327631-A2 Fused heterocyclic compounds, their production and use as angiotensin II antagonists Takeda Chemical Industries, Ltd. (JP) 2003-07-16 EP disclosed
EP-0518033-B1 Fused heterocyclic compounds, their production and use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2003-07-02 EP disclosed
US-5389641-A Fused heterocyclic compounds, having angiotensin II antagonistic activity TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1995-02-14 US disclosed
EP-0518033-A1 Fused heterocyclic compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-12-16 EP disclosed